Novonesis (Novozymes A/S) (NVZMY) Enterprise Value: 28.97B

Novonesis (Novozymes A/S) (NVZMY)

62.60 +0.44 (+0.71%) USD | OTCM | Oct 02, 16:00

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2003. Start Trial.

Date	Value
October 02, 2026	28.97B
October 01, 2026	28.79B
September 30, 2026	29.31B
September 29, 2026	29.32B
September 28, 2026	29.89B
September 25, 2026	29.97B
September 24, 2026	30.96B
September 23, 2026	30.65B
September 22, 2026	31.04B
September 21, 2026	30.38B
September 18, 2026	30.27B
September 17, 2026	30.22B
September 16, 2026	30.47B
September 15, 2026	30.44B
September 14, 2026	30.55B
September 11, 2026	30.47B
September 10, 2026	30.33B
September 09, 2026	30.93B
September 08, 2026	31.08B
September 04, 2026	31.22B
September 03, 2026	32.15B
September 02, 2026	32.36B
September 01, 2026	32.12B
August 31, 2026	32.71B
August 28, 2026	32.80B

Date	Value
August 27, 2026	32.61B
August 26, 2026	32.44B
August 25, 2026	32.17B
August 24, 2026	32.66B
August 21, 2026	32.06B
August 20, 2026	32.24B
August 19, 2026	31.82B
August 18, 2026	29.63B
August 17, 2026	29.74B
August 14, 2026	30.23B
August 13, 2026	29.63B
August 12, 2026	29.66B
August 11, 2026	29.76B
August 10, 2026	30.21B
August 07, 2026	30.36B
August 06, 2026	30.15B
August 05, 2026	30.06B
August 04, 2026	29.57B
August 03, 2026	29.34B
July 31, 2026	29.98B
July 30, 2026	30.30B
July 29, 2026	29.34B
July 28, 2026	29.71B
July 27, 2026	28.50B
July 24, 2026	28.91B

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks